ALKS
Alkermes plc.Company with tickers: ALKS
CIK
1520262
CUSIP
G01767105
Shares Outstanding
166,675,807
13F Activity (30d)
338 filings
329 filers
Price
$36.70
Market Cap
$6.13B
P/E Ratio
25.66
EPS (Diluted)
$1.43
52W High
$39.12
52W Low
$25.17
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-21 | LAURENCIN CATO T | Director | Convert | 6,142 |
| 2026-05-21 | LAURENCIN CATO T | Director | Tax | 1,475 |
| 2026-05-21 | LAURENCIN CATO T | Director | Convert | 6,142 |
| 2026-05-21 | MCKEON BRIAN P | EVP, CFO and Treasurer | Convert | 6,142 |
| 2026-05-21 | MCKEON BRIAN P | EVP, CFO and Treasurer | Tax | 1,475 |
| 2026-05-21 | MCKEON BRIAN P | EVP, CFO and Treasurer | Convert | 6,142 |
| 2026-05-21 | Wilson Frank Anders | Director | Convert | 6,142 |
| 2026-05-21 | Wilson Frank Anders | Director | Convert | 6,142 |
| 2026-05-21 | Wilson Frank Anders | Director | Tax | 1,475 |
| 2026-05-21 | Lurker Nancy | Director | Convert | 6,142 |
| 2026-05-21 | Lurker Nancy | Director | Tax | 1,475 |
| 2026-05-21 | Lurker Nancy | Director | Convert | 6,142 |
| 2026-05-21 | snyderman nancy lynn MD | Director | Convert | 6,142 |
| 2026-05-21 | snyderman nancy lynn MD | Director | Convert | 6,142 |
| 2026-05-21 | snyderman nancy lynn MD | Director | Tax | 1,475 |
| 2026-05-21 | Wright Christopher I | Chief Medical Officer | Convert | 6,142 |
| 2026-05-21 | Wright Christopher I | Chief Medical Officer | Convert | 6,142 |
| 2026-05-21 | Wright Christopher I | Chief Medical Officer | Tax | 1,475 |
| 2026-05-21 | Cooke Shane | Director | Convert | 6,142 |
| 2026-05-21 | Cooke Shane | Director | Convert | 6,142 |
| 2026-05-21 | Cooke Shane | Director | Tax | 3,207 |
| 2026-05-21 | GAYNOR RICHARD | Director | Convert | 6,142 |
| 2026-05-21 | GAYNOR RICHARD | Director | Tax | 1,475 |
| 2026-05-21 | GAYNOR RICHARD | Director | Convert | 6,142 |
| 2026-05-20 | LAURENCIN CATO T | Director | Award | 11,538 |
| 2026-05-20 | LAURENCIN CATO T | Director | Award | 5,409 |
| 2026-05-20 | MCKEON BRIAN P | EVP, CFO and Treasurer | Award | 11,538 |
| 2026-05-20 | MCKEON BRIAN P | EVP, CFO and Treasurer | Other | 10,000 |
| 2026-05-20 | MCKEON BRIAN P | EVP, CFO and Treasurer | Award | 5,409 |
| 2026-05-20 | Wilson Frank Anders | Director | Award | 5,409 |
| 2026-05-20 | Wilson Frank Anders | Director | Award | 11,538 |
| 2026-05-20 | Lurker Nancy | Director | Award | 5,409 |
| 2026-05-20 | Lurker Nancy | Director | Award | 11,538 |
| 2026-05-20 | snyderman nancy lynn MD | Director | Other | 20,783 |
| 2026-05-20 | snyderman nancy lynn MD | Director | Award | 11,538 |
| 2026-05-20 | snyderman nancy lynn MD | Director | Award | 5,409 |
| 2026-05-20 | Wright Christopher I | Chief Medical Officer | Award | 11,538 |
| 2026-05-20 | Wright Christopher I | Chief Medical Officer | Award | 5,409 |
| 2026-05-20 | Cooke Shane | Director | Award | 11,538 |
| 2026-05-20 | Cooke Shane | Director | Award | 5,409 |
| 2026-05-20 | GAYNOR RICHARD | Director | Award | 5,409 |
| 2026-05-20 | GAYNOR RICHARD | Director | Award | 11,538 |
| 2026-05-04 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 2,034 |
| 2026-05-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Convert | 5,000 |
| 2026-05-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 9,000 |
| 2026-05-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Convert | 5,000 |
| 2026-04-11 | Lurker Nancy | Director | Convert | 3,751 |
| 2026-04-11 | Lurker Nancy | Director | Convert | 3,751 |
| 2026-04-11 | Lurker Nancy | Director | Tax | 901 |
| 2026-04-06 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 2,034 |
| 2026-04-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Convert | 5,000 |
| 2026-04-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 9,000 |
| 2026-04-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Convert | 5,000 |
| 2026-03-03 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 2,034 |
| 2026-03-02 | Jackson Blair Curtis | EVP, Chief Operating Officer | Award | 44,078 |
| 2026-03-02 | Jackson Blair Curtis | EVP, Chief Operating Officer | Award | 94,900 |
| 2026-03-02 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Award | 83,037 |
| 2026-03-02 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Convert | 5,000 |
| 2026-03-02 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 9,000 |
| 2026-03-02 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Convert | 5,000 |
| 2026-03-02 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Award | 38,568 |
| 2026-03-02 | Reed Joshua | Director | Award | 30,854 |
| 2026-03-02 | Reed Joshua | Director | Award | 66,430 |
| 2026-03-02 | POPS RICHARD F | Director | Award | 88,843 |
| 2026-03-02 | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Award | 14,176 |
| 2026-03-02 | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Award | 15,033 |
| 2026-03-02 | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Sell | 6,890 |
| 2026-03-02 | Nichols Christian Todd | SVP, Chief Commercial Officer | Award | 30,854 |
| 2026-03-02 | Nichols Christian Todd | SVP, Chief Commercial Officer | Award | 66,430 |
| 2026-03-02 | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 6,000 |
| 2026-03-02 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Award | 78,292 |
| 2026-03-02 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Award | 36,364 |
| 2026-03-02 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 2,034 |
| 2026-02-26 | Nichols Christian Todd | SVP, Chief Commercial Officer | Tax | 2,403 |
| 2026-02-26 | Nichols Christian Todd | SVP, Chief Commercial Officer | Convert | 5,410 |
| 2026-02-26 | Nichols Christian Todd | SVP, Chief Commercial Officer | Convert | 5,410 |
| 2026-02-26 | Jackson Blair Curtis | EVP, Chief Operating Officer | Convert | 8,322 |
| 2026-02-26 | Jackson Blair Curtis | EVP, Chief Operating Officer | Tax | 3,695 |
| 2026-02-26 | Jackson Blair Curtis | EVP, Chief Operating Officer | Convert | 8,322 |
| 2026-02-26 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Tax | 3,049 |
| 2026-02-26 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Convert | 6,866 |
| 2026-02-26 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Convert | 6,866 |
| 2026-02-26 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Convert | 6,866 |
| 2026-02-26 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Convert | 6,866 |
| 2026-02-26 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Tax | 3,049 |
| 2026-02-26 | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Tax | 808 |
| 2026-02-26 | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Convert | 2,747 |
| 2026-02-26 | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Convert | 2,747 |
| 2026-02-23 | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Convert | 2,283 |
| 2026-02-23 | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Convert | 2,283 |
| 2026-02-23 | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Tax | 672 |
| 2026-02-23 | Nichols Christian Todd | SVP, Chief Commercial Officer | Convert | 6,407 |
| 2026-02-23 | Nichols Christian Todd | SVP, Chief Commercial Officer | Tax | 2,845 |
| 2026-02-23 | Nichols Christian Todd | SVP, Chief Commercial Officer | Convert | 6,407 |
| 2026-02-23 | Jackson Blair Curtis | EVP, Chief Operating Officer | Convert | 8,738 |
| 2026-02-23 | Jackson Blair Curtis | EVP, Chief Operating Officer | Tax | 3,880 |
| 2026-02-23 | Jackson Blair Curtis | EVP, Chief Operating Officer | Convert | 8,738 |
| 2026-02-23 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Tax | 3,414 |
| 2026-02-23 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Convert | 7,689 |
| 2026-02-23 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Convert | 7,689 |